NUVB logo

Nuvation Bio (NUVB) Selling, General & Administrative Expenses

Annual SG&A

$28.53 M
-$3.39 M-10.61%

31 December 2023

NUVB Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$19.58 M
+$3.43 M+21.21%

01 September 2024

NUVB Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

-$2.38 B
-$532.28 M-28.78%

01 September 2024

NUVB TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NUVB Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.6%+151.8%-7904.8%
3 y3 years+160.6%+245.4%-10000.0%
5 y5 years---

NUVB Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-10.6%+160.6%at high+257.3%-459.5%at low
5 y5 years-10.6%+160.6%at high+1071.2%-3035.8%at low
alltimeall time-10.6%+160.6%at high+1071.2%-3035.8%at low

Nuvation Bio Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$19.58 M(+21.2%)
$48.58 M(+32.1%)
June 2024
-
$16.16 M(+119.6%)
$36.77 M(+30.6%)
Mar 2024
-
$7.36 M(+34.3%)
$28.16 M(-1.3%)
Dec 2023
$28.53 M(-10.6%)
$5.48 M(-29.5%)
$28.53 M(-6.5%)
Sept 2023
-
$7.78 M(+3.1%)
$30.52 M(-0.9%)
June 2023
-
$7.54 M(-2.5%)
$30.78 M(-4.4%)
Mar 2023
-
$7.73 M(+3.6%)
$32.19 M(+0.8%)
Dec 2022
$31.92 M
$7.46 M(-7.2%)
$31.92 M(-0.4%)
Sept 2022
-
$8.04 M(-10.1%)
$32.06 M(+8.0%)
DateAnnualQuarterlyTTM
June 2022
-
$8.95 M(+19.9%)
$29.69 M(+9.4%)
Mar 2022
-
$7.46 M(-1.9%)
$27.14 M(+11.8%)
Dec 2021
$24.28 M(+121.8%)
$7.61 M(+34.2%)
$24.28 M(+15.0%)
Sept 2021
-
$5.67 M(-11.4%)
$21.11 M(+15.0%)
June 2021
-
$6.40 M(+39.0%)
$18.36 M(+34.7%)
Mar 2021
-
$4.61 M(+3.9%)
$13.63 M(+24.5%)
Dec 2020
$10.95 M
$4.43 M(+51.8%)
$10.95 M(+68.0%)
Sept 2020
-
$2.92 M(+74.6%)
$6.52 M(+81.2%)
June 2020
-
$1.67 M(-13.1%)
$3.60 M(+86.9%)
Mar 2020
-
$1.93 M
$1.93 M

FAQ

  • What is Nuvation Bio annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Nuvation Bio?
  • What is Nuvation Bio annual SG&A year-on-year change?
  • What is Nuvation Bio quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Nuvation Bio?
  • What is Nuvation Bio quarterly SG&A year-on-year change?
  • What is Nuvation Bio TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Nuvation Bio?
  • What is Nuvation Bio TTM SG&A year-on-year change?

What is Nuvation Bio annual selling, general & administrative expenses?

The current annual SG&A of NUVB is $28.53 M

What is the all time high annual SG&A for Nuvation Bio?

Nuvation Bio all-time high annual selling, general & administrative expenses is $31.92 M

What is Nuvation Bio annual SG&A year-on-year change?

Over the past year, NUVB annual selling, general & administrative expenses has changed by -$3.39 M (-10.61%)

What is Nuvation Bio quarterly selling, general & administrative expenses?

The current quarterly SG&A of NUVB is $19.58 M

What is the all time high quarterly SG&A for Nuvation Bio?

Nuvation Bio all-time high quarterly selling, general & administrative expenses is $19.58 M

What is Nuvation Bio quarterly SG&A year-on-year change?

Over the past year, NUVB quarterly selling, general & administrative expenses has changed by +$11.80 M (+151.76%)

What is Nuvation Bio TTM selling, general & administrative expenses?

The current TTM SG&A of NUVB is -$2.38 B

What is the all time high TTM SG&A for Nuvation Bio?

Nuvation Bio all-time high TTM selling, general & administrative expenses is $48.58 M

What is Nuvation Bio TTM SG&A year-on-year change?

Over the past year, NUVB TTM selling, general & administrative expenses has changed by -$2.41 B (-7904.78%)